ArticleDiabetology & metabolic syndrome2025
Association between coffee and tea consumption and the risk of macrovascular complications in type 2 diabetes: a UK Biobank cohort study.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Habitual coffee consumption and risk of incident heart failure: an updated systematic review and dose-response meta-analysis of prospective cohort studies.Journal of health, population, and nutrition · 2026Pooled it
- Electroacupuncture ameliorates glycolipid metabolism disorder in skeletal muscle of type 2 diabetic rats via modulation of the AMPK/PGC-1α/TFAM signaling pathway.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany studies have shown that coffee and tea consumption is associated with diabetes. However, limited research exists on their effects on the risk of macrovascular complications in diabetic patients. Therefore, the purpose of this study was to examine the relationship between the intake of coffee and tea and macrovascular complications in patients with type 2 diabetes mellitus (T2DM).
methodsWe used the Cox proportional hazards regression model to estimate the hazard ratio (HR) and 95% confidence interval (CI), which determined the relationship between coffee and tea consumption and the risk of macrovascular complications among 14,277 UK Biobank participants.
resultsCompared with non-coffee or tea drinkers, those who consumed 0.5-1 cup of coffee (HR 0.67,95% CI 0.518 to 0.856) or 2-4 cups of tea (HR 0.66,95% CI 0.524 to 0.839) per day had the lowest risk of stroke; daily intake of 2-4 cups of coffee associated with reduced risk of angina pectoris (AP) (HR 0.82,95% CI 0.726 to 0.916); those who consumed 0.5-1 cup of tea per day had the lowest risk of the heart failure (HF) (HR 0.73,95% CI 0.602 to 0.879); furthermore, those who consumed 2-4 cups of coffee and 0.5-1 cup of tea per day (HR 0.55, 95% CI 0.379-0.790) demonstrated the lowest risk of HF onset compared with those who did not consume coffee and tea at all.
conclusionsThis study found that in a T2DM population, moderate coffee consumption significantly lowered the risk of stroke and AP, while moderate tea intake reduced the risk of stroke and HF. Combined moderate consumption of both beverages provided optimal protection against HF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.